Celltrion Of S. Korea Seeks World's First Approval Of Herceptin Generic
This article was originally published in PharmAsia News
Executive Summary
South Korea's Celltrion hopes to be the world's first pharmaceutical maker to get a generic version of a biotech antibody drug into clinical trials